Cargando…
Supervised injection facilities in Canada: past, present, and future
Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of supervised injection facilities (SIFs), and after several unsanctioned SIFs operated briefly and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437687/ https://www.ncbi.nlm.nih.gov/pubmed/28521829 http://dx.doi.org/10.1186/s12954-017-0154-1 |
_version_ | 1783237641411493888 |
---|---|
author | Kerr, Thomas Mitra, Sanjana Kennedy, Mary Clare McNeil, Ryan |
author_facet | Kerr, Thomas Mitra, Sanjana Kennedy, Mary Clare McNeil, Ryan |
author_sort | Kerr, Thomas |
collection | PubMed |
description | Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of supervised injection facilities (SIFs), and after several unsanctioned SIFs operated briefly and closed, Canada’s first sanctioned SIF opened in 2003. However, while a large body of evidence highlights the successes of this SIF in reducing the health and social harms associated with injection drug use, extraordinary efforts were needed to preserve it, and continued activism by local people who inject drugs (PWID) and healthcare providers was needed to promote further innovation and address gaps in SIF service delivery. A growing acceptance of SIFs and increasing concern about overdose have since prompted a rapid escalation in efforts to establish SIFs in cities across Canada. While much progress has been made in that regard, there is a pressing need to create a more enabling environment for SIFs through amendment of federal legislation. Further innovation in SIF programming should also be encouraged through the creation of SIFs that accommodate assisted injecting, the inhalation of drugs. As well, peer-run, mobile, and hospital-based SIFs also constitute next steps needed to optimize the impact of this form of harm reduction intervention. |
format | Online Article Text |
id | pubmed-5437687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54376872017-05-22 Supervised injection facilities in Canada: past, present, and future Kerr, Thomas Mitra, Sanjana Kennedy, Mary Clare McNeil, Ryan Harm Reduct J Review Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of supervised injection facilities (SIFs), and after several unsanctioned SIFs operated briefly and closed, Canada’s first sanctioned SIF opened in 2003. However, while a large body of evidence highlights the successes of this SIF in reducing the health and social harms associated with injection drug use, extraordinary efforts were needed to preserve it, and continued activism by local people who inject drugs (PWID) and healthcare providers was needed to promote further innovation and address gaps in SIF service delivery. A growing acceptance of SIFs and increasing concern about overdose have since prompted a rapid escalation in efforts to establish SIFs in cities across Canada. While much progress has been made in that regard, there is a pressing need to create a more enabling environment for SIFs through amendment of federal legislation. Further innovation in SIF programming should also be encouraged through the creation of SIFs that accommodate assisted injecting, the inhalation of drugs. As well, peer-run, mobile, and hospital-based SIFs also constitute next steps needed to optimize the impact of this form of harm reduction intervention. BioMed Central 2017-05-18 /pmc/articles/PMC5437687/ /pubmed/28521829 http://dx.doi.org/10.1186/s12954-017-0154-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Kerr, Thomas Mitra, Sanjana Kennedy, Mary Clare McNeil, Ryan Supervised injection facilities in Canada: past, present, and future |
title | Supervised injection facilities in Canada: past, present, and future |
title_full | Supervised injection facilities in Canada: past, present, and future |
title_fullStr | Supervised injection facilities in Canada: past, present, and future |
title_full_unstemmed | Supervised injection facilities in Canada: past, present, and future |
title_short | Supervised injection facilities in Canada: past, present, and future |
title_sort | supervised injection facilities in canada: past, present, and future |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437687/ https://www.ncbi.nlm.nih.gov/pubmed/28521829 http://dx.doi.org/10.1186/s12954-017-0154-1 |
work_keys_str_mv | AT kerrthomas supervisedinjectionfacilitiesincanadapastpresentandfuture AT mitrasanjana supervisedinjectionfacilitiesincanadapastpresentandfuture AT kennedymaryclare supervisedinjectionfacilitiesincanadapastpresentandfuture AT mcneilryan supervisedinjectionfacilitiesincanadapastpresentandfuture |